Randomized, open-label, phase 2 study of nivolumab plus ipilimumab or nivolumab monotherapy in patients with advanced or metastatic solid tumors of high tumor mutational burden - Concepedia

Concepedia

Publication | Open Access

Randomized, open-label, phase 2 study of nivolumab plus ipilimumab or nivolumab monotherapy in patients with advanced or metastatic solid tumors of high tumor mutational burden

DOI Full Paper Access

32

Citations

24

References

2024

Year

Michael Schenker, Mauricio Burotto, Martin Eduardo Richardet, Tudor–Eliade Ciuleanu, Anthony Gonçalves, Neeltje Steeghs, Patrick Schöffski, Paolo A. Ascierto, Michele Maio, Iwona Ługowska,

Journal for ImmunoTherapy of Cancer

Abstract

NCT03668119.

References

	Year	Citations

Page 1